Skip to main content

Advertisement

Table 2 Study and Participant Characteristics

From: Impact of wearable physical activity monitoring devices with exercise prescription or advice in the maintenance phase of cardiac rehabilitation: systematic review and meta-analysis

StudyCountry of OriginNo. ParticipantsGender (f/m)Age (years±SD)DiagnosisStudy Duration (months)% of participants completed study
Avila et al. [67]Belgium30 c 60 i 84a3/27 c 4/26 i61.7 ± 7.7 c 58.6 ± 13 iCAD, MI, CABG, PCI386.67 c 93.33 i
Butler et al. [68]Australia60 c, 62 i 6/52: 50 c, 48 i; 98a 6/12: 46 c, 44 I; 90a10/45 c 17/38 i64.5 ± 11.2 c 63 ± 10.4 iMI, CABG, PCI, ACS66/52: 90.9 c; 87.3 i 6/12: 83.64 c; 80 i
Cupples et al. [69]Northern Ireland26 c 19 i1/25 c 3/16 i59.2 ± 8.9 c 61.6 ± 11.3 iNot published1.596 c 90 i
Duscha et al. [70]America11 c 21 i; 25a3/6 c 3/13 i66.5 ± 7.2 c 59.9 ± 8.1 iMI with PCI or CABG, PCI, CABG, VR381.8 c 76.2 i
Guiraud et al. [71]France10 c 19 i3/7 c 2/17 i62.9 ± 10.7 c 54.5 ± 12.6 iCAD, CABG, PCI, HF2100 c 100 i
Houle et al. [72]Canada33 c 32 i8/25 c 6/26 i59 ± 9 c 58 ± 8 iMI, CABG, PCI, UA12Data not published
Skobel et al. [73]Germany, Spain, Britain63 c 55 i 54a:42 c,12 i8/55 c 5/ 50 i58 c* 60 i*MI, PCI666.7 c, 21.8 i
ter Hoeve et al. [52]Netherlands163 c 161 i32/131 c 32/129 i59.1 ± 8 c 58.8 ± 9 iMI, CABG, PCI, ACS183/12: 78 c, 80.1 i 12/12: 75 c,75 i 18/12: 74.7 c,74.8 i
Varnfield et al. [53]Australia41 c 53 i 6/52:28 c 48 i; 76a 6/12: 26 c, 46 i; 72a7/34 c 5/48 i56.2 ± 10.1 c 54.9 ± 9.6 iMY66/52:46.7 c, 80 i 6/12:43.3 c,76.7 i
  1. Abbreviations: f female, m male, SD standard deviation, t total, c control, i intervention, a analysed, CAD coronary artery disease, MI myocardial infarction, CABG coronary artery bypass graft surgery, PCI percutaneous coronary intervention, ACS acute coronary syndrome, VR valve repair, HF heart failure, UA unstable angina, wks weeks, m months,a: *SD not published